Biotech enjoys strong financial backing in Medicon Valley. There are about 60 venture capitalists investing in the region, covering all phases of investment.
Biotech enjoys strong financial backing in Medicon Valley. There
are about 60 venture capitalists investing in the region, covering
all phases of investment. These include BankInvest Biomedicinsk
Udvikling and Scandinavian Life Science Ventures and several
others focused solely on life science investments.
In Medicon Valley, investors usually take a long-term view on
their investments, and they often increase their investments.
Recent years’ upspring of new biotechnological companies in
Medicon Valley has also created an international interest in the
investment opportunities in the region. Several foreign venture
companies such as the UK based 3i, the Finnish BIO Fund and the
Geneva based Index Ventures are actively investing within Medicon
Valley.
When ACADIA Pharmaceuticals chose to place their first
subsidiary in Copenhagen, the excellent financing
opportunities in Copenhagen were among the deciding factors for the
choice of location.
For more information, see the guide regarding venture capital
here.
